Rejuvel Bio-Sciences, Inc.
Rejuvel Bio-Sciences, Inc.
Your view on NUUU
Overview
What the company does, where it operates, and who runs it.
About Rejuvel Bio-Sciences, Inc.
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- CEO
- Charles J. Scimeca
- Headquarters
- Chase Bank Building, Miami, FL, US
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- CEO
- Charles J. Scimeca
- Headquarters
- Chase Bank Building, Miami, FL, US
Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand.
It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities.
The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Rejuvel Bio-Sciences, Inc., and the rating behind it. NUUU last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Rejuvel Bio-Sciences, Inc.. Starting points for Rejuvel Bio-Sciences, Inc.: beta -131.85 — an Household & Personal Products name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Rejuvel Bio-Sciences, Inc.. Rejuvel Bio-Sciences, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Rejuvel Bio-Sciences, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Rejuvel Bio-Sciences, Inc.. Rejuvel Bio-Sciences, Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Rejuvel Bio-Sciences, Inc. valued side by side against its closest peers. Rejuvel Bio-Sciences, Inc. is measured against Household & Personal Products peers within the Consumer Defensive sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Rejuvel Bio-Sciences, Inc., and how their positions are changing. At a $117,765 market value, institutional positions materially move Rejuvel Bio-Sciences, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Rejuvel Bio-Sciences, Inc. executives and directors. Shares of Rejuvel Bio-Sciences, Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Rejuvel Bio-Sciences, Inc.. Rejuvel Bio-Sciences, Inc. is a $117,765 Consumer Defensive company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Rejuvel Bio-Sciences, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Rejuvel Bio-Sciences, Inc.. Coverage tracks Rejuvel Bio-Sciences, Inc. within Household & Personal Products (Consumer Defensive). Press releases and market coverage, newest first.